MARKSANS PHARMA LTD.

NSE : MARKSANSBSE : 524404ISIN CODE : INE750C01026Industry : Pharmaceuticals & DrugsHouse : Private

BSE63.65-0.15 (-0.24 %)

PREV CLOSE ( ) 63.80

OPEN PRICE ( ) 64.15

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 524634

TODAY'S LOW / HIGH ( )61.45 64.40

52 WK LOW / HIGH ( )38.7 64.9

NSE63.60-0.2 (-0.31 %)

PREV CLOSE( ) 63.80

OPEN PRICE ( ) 63.80

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 63.60 (2844)

VOLUME 3355631

TODAY'S LOW / HIGH( ) 61.50 64.45

52 WK LOW / HIGH ( )38.6 65

More From Company Profile

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992

Management Info

Mark Saldanha - Chairman Mark Saldanha - Managing Director

Registered Office

Address 11th Floor, " Grandeur ",Opp. Gundecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W),
Mumbai,
Maharashtra-400053

Phone 022- 40012000

Email info@marksanspharma.com

Website www.marksanspharma.com

Registrars Details

Bigshare Services Pvt Ltd

Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai

Listing : BSE, NSE

NEWS

02Nov Marksans Pharma informs about daily re
With reference to the Buyback of equity shares of Re 1 each of the compa..

25Oct Marksans Pharma informs about buyback
Marksans Pharma has informed that it submitted the daily report pursuant..

12Oct Marksans Pharma shines on entering int
Marksans Pharma is currently trading at Rs. 48.95, up by 2.30 points or..

12Oct D B Realty, Marksans Pharma and Genesy
D B Realty has acquired entire equity shares of Spacecon Realty (Spaceco..

11Oct Marksans Pharma enters into Business T
Marksans Pharma has entered into a Business Transfer Agreement with Teva..

Financials

in Millions

	QTR Sep 22	ANNUAL 22
Net Profit	402.29	1039.88
Gross Profit	489.84	1345.08
Operating Profit	548.05	1559.66
Net Sales	1702.59	6582.89

EVENT CALENDAR

peer group

Procter&Gamble Healt (BSE) 4159.50 (1.65%)	M.Cap ( in Cr)6904.51
RPG Life Sciences (BSE) 912.65 (4.85%)	M.Cap ( in Cr)1509.43
Samrat Pharmachem (BSE) 827.45 (5.00%)	M.Cap ( in Cr)255.66
Hikal (BSE) 384.85 (9.63%)	M.Cap ( in Cr)4745.23
Glaxosmithkline Phar (BSE) 1339.45 (0.85%)	M.Cap ( in Cr)22691.09

	PROMOTERS	48.6%
	NON-INSTITUTION	46.38%
	MUTUAL FUNDS/UTI	0.95%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Scheme Name	Hold(%)
Quant Small Cap Fund(G)	0.82
Motilal Oswal S&P B...	0.16

About Marksans Pharma Ltd.

Marksans Pharma Ltd. was incorporated in the year 1992. Its today's share price is 63.65. Its current market capitalisation stands at Rs 2565.25 Cr. In the latest quarter, company has reported Gross Sales of Rs. 6653.02 Cr and Total Income of Rs.7005.4 Cr. The company's management includes Harshavardhan Panigrahi, Sunny Sharma, Meena Surana, Abhinna Sundar Mohanty, Digant Mahesh Parikh, Seetharama Raju Buddharaju, Varddhman Vikramaditya Jain, Sandra Saldanha, Mark Saldanha, Mark Saldanha.

It is listed on the BSE with a BSE Code of 524404 , NSE with an NSE Symbol of MARKSANS and ISIN of INE750C01026. It's Registered office is at 11th Floor, " Grandeur ",Opp. Gundecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W)Mumbai-400053, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Bhuta Shah & Co LLP, NK Mittal & Associates, VS Lalpuria & Co

About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang Contact Dp Support Contact Trading Support

Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading

Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays

Derivatives Updates Market Report Overview

IPO IPO Issues Performance News & Analysis

Commodities Market Movers News & Commentary MCX / NCDEX Holidays MCX Data feed product and Charges

Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Annual Return 2018 Annual Return 2017 Mutual Fund Terms & Conditions Mutual Privacy Policy

Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research

Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap Do's And Dont's

Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances SEBI Scores RMS Policy Inspection CSR Committee CSR Policy CSR Activities FY-2020-2021 FY-2021-2022 Investor Charter Linked content_Investor Charter for Depositories and DPs Investor Charter for Depositories and DPs Investor Charter for Stock Broker Investor Charter for Research Investor Complaints -RA Investor Complaints-NBEPL

Investor Complaint Data

Connect with Us

ATTENTION INVESTORS Depository IPO KYC

Inactive account treatment NBSPL Policy of AML NBEPL Policy of AML NBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar Updation Nirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019

Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300

For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain. |

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Type	Charges (POA Clients)	Charges (Non-POA Clients)
Margin Pledge Creation/Initiation	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)
Margin Pledge Release	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)

Stock Price Quote